We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
-2.15%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$322M
AUM Growth
-$133M
(-29%)
Cap. Flow
-$85.3M
Cap. Flow
% of AUM
-26.5%
Top 10 Holdings %
Top 10 Hldgs %
11.34%
Holding
325
New
83
Increased
75
Reduced
45
Closed
120
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Magnite
MGNI
|
+$3.56M |
| 2 |
AtriCure
ATRC
|
+$3.08M |
| 3 |
Ameresco
AMRC
|
+$3.05M |
| 4 |
Teladoc Health
TDOC
|
+$2.97M |
| 5 |
Sprout Social
SPT
|
+$2.86M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PRFT
Perficient Inc
PRFT
|
+$5.02M |
| 2 |
CUTR
Cutera, Inc.
CUTR
|
+$4.72M |
| 3 |
Alphatec Holdings
ATEC
|
+$4.58M |
| 4 |
Boot Barn
BOOT
|
+$4.2M |
| 5 |
BDSI
BioDelivery Sciences International, Inc.
BDSI
|
+$4.14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.85% |
| 2 | Technology | 22.09% |
| 3 | Industrials | 12.85% |
| 4 | Financials | 4.49% |
| 5 | Consumer Discretionary | 4.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NBSE
176
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $741K | 0.23% |
5,201
+208
| +4% | +$27.5K |
|
|
BLU
177
DELISTED
BELLUS Health Inc.
BLU
| $727K | 0.23% |
+72,811
| New | +$649K |
|
178
NextCure
NXTC
$23.8M
| $722K | 0.22% |
1,624
-1,068
| -40% | -$570K |
|
179
Milestone Scientific
MLSS
$42.6M
| $706K | 0.22% |
565,071
+22,560
| +4% | +$40.7K |
|
|
SILV
180
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $666K | 0.21% |
128,637
-38
| -0% | -$240 |
|
181
LGL Group
LGL
$46.5M
| $662K | 0.21% |
196,704
+7,879
| +4% | +$36.9K |
|
182
Photronics
PLAB
$1.93B
| $651K | 0.2% |
63,464
-131,176
| -67% | -$1.72M |
|
183
Perma-Fix Environmental Services
PESI
$383M
| $626K | 0.19% |
120,084
+4,799
| +4% | +$34K |
|
|
CEMI
184
DELISTED
Chembio diagnostics, Inc.
CEMI
| $613K | 0.19% |
+119,666
| New | +$484K |
|
185
Stereotaxis
STXS
$141M
| $610K | 0.19% |
202,071
+8,063
| +4% | +$33.3K |
|
|
RADA
186
DELISTED
Rada Electronic Industries Ltd
RADA
| $609K | 0.19% |
174,137
+32,497
| +23% | +$168K |
|
|
PROF
187
Profound Medical
PROF
$269M
| $605K | 0.19% |
+63,602
| New | +$825K |
|
|
BCLI
188
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $603K | 0.19% |
+8,662
| New | +$676K |
|
189
Perion Network
PERI
$386M
| $597K | 0.19% |
+122,006
| New | +$876K |
|
190
Innovative Solutions & Support
ISSC
$361M
| $582K | 0.18% |
182,570
+7,286
| +4% | +$37.2K |
|
191
Verastem
VSTM
$592M
| $575K | 0.18% |
+18,147
| New | +$455K |
|
192
Perspective Therapeutics
CATX
$342M
| $573K | 0.18% |
+108,105
| New | +$816K |
|
193
Ovid Therapeutics
OVID
$491M
| $550K | 0.17% |
184,728
-100,337
| -35% | -$338K |
|
|
SUNE
194
SUNation Energy
SUNE
$10.8M
| – | – |
0
| – | – |
|
195
Kornit Digital
KRNT
$791M
| $513K | 0.16% |
20,598
-8,636
| -30% | -$323K |
|
196
Axcelis
ACLS
$4.31B
| $509K | 0.16% |
27,803
-31,510
| -53% | -$732K |
|
197
Crown Crafts
CRWS
$32.3M
| $506K | 0.16% |
105,823
+4,227
| +4% | +$25K |
|
198
ClearPoint Neuro
CLPT
$433M
| $489K | 0.15% |
+136,525
| New | +$671K |
|
|
FPAY
199
DELISTED
FlexShopper
FPAY
| $457K | 0.14% |
359,859
+137,362
| +62% | +$310K |
|
|
BRT
200
BRT Apartments
BRT
$271M
| $417K | 0.13% |
40,676
-12,305
| -23% | -$190K |
|
Similar funds
RWM
MCM
HP
OMG
WFAL
WCM
TSS
F1I
EAM Investors's Q1 2020 Portfolio in Review
As of Q1 2020, EAM Investors held 325 positions worth $322M, down 29% from $455M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
EAM Investors withdrew a net $85.3M in Q1 2020, closing 120 positions and reducing 45 holdings. Its most notable exit was Perficient Inc, an estimated $5.02M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 33% a quarter earlier, followed by Technology and Industrials.
Against the trend, EAM Investors opened a new position in Magnite worth $2.15M.
- EAM Investors's largest Q1 2020 buy was Magnite: 387,046 shares worth $2.15M.
- EAM Investors added most to Orion Energy Systems in Q1 2020, an estimated $2.12M increase.
- EAM Investors's biggest Q1 2020 reduction was Dicerna Pharmaceuticals, Inc., cutting an estimated $1.99M.
- EAM Investors fully exited Perficient Inc in Q1 2020, selling an estimated $5.02M.
- EAM Investors's ten largest holdings make up 11% of its $322M portfolio in Q1 2020.
- EAM Investors opened 83 new positions and closed 120 in Q1 2020.
- EAM Investors's portfolio value fell 29% quarter-over-quarter to $322M.
Based on EAM Investors's 13F filing for Q1 2020, filed 13 May 2020.